Normal view MARC view ISBD view

Managed entry agreements and funding for expensive therapies / (Record no. 55949)

MARC details
000 -LEADER
fixed length control field	03129nam a2200601 i 4500
001 - CONTROL NUMBER
control field	on1305944541
003 - CONTROL NUMBER IDENTIFIER
control field	EBZ
005 - DATE AND TIME OF LATEST TRANSACTION
control field	20251029164100.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field	m d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field	cr \|\|\|\|\|\|\|\|\|\|\|
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field	220311s2022 flu ob 001 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number	2021059396
040 ## - CATALOGING SOURCE
Original cataloging agency	EBZ
Language of cataloging	eng
Transcribing agency	EBZ
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number	9781000594676
Qualifying information	(epub)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number	100059467X
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number	9781003048565
Qualifying information	(ebook)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number	1003048560
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number	9781000594638
Qualifying information	(electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number	1000594637
Qualifying information	(electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN	9780367500269
Qualifying information	(paperback)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN	9780367500290
Qualifying information	(hardback)
042 ## - AUTHENTICATION CODE
Authentication code	pcc
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number	RA410.5
049 ## - LOCAL HOLDINGS (OCLC)
Holding library	MAIN
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name	Toumi, Mondher,
Relator term	author.
9 (RLIN)	64240
245 10 - TITLE STATEMENT
Title	Managed entry agreements and funding for expensive therapies /
Statement of responsibility, etc.	Mondher Toumi, Szymon Jaroslawski.
250 ## - EDITION STATEMENT
Edition statement	First edition.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture	Boca Raton :
Name of producer, publisher, distributor, manufacturer	CRC Press,
Date of production, publication, distribution, manufacture, or copyright notice	2022.
300 ## - PHYSICAL DESCRIPTION
Extent	1 online resource.
336 ## - CONTENT TYPE
Content type term	text
Content type code	txt
Source	rdacontent
337 ## - MEDIA TYPE
Media type term	computer
Media type code	c
Source	rdamedia
338 ## - CARRIER TYPE
Carrier type term	online resource
Carrier type code	cr
Source	rdacarrier
341 0# -
--	textual
--	sapdv
--	EBSCOhost
490 0# - SERIES STATEMENT
Series statement	Pharmaceuticals, health economics and market access
532 #0 -
--	EBSCOhost
--	"EBSCO evaluates our products based on the Web Content Accessibility Guidelines (WCAG) and the related Section 508 and EN 301 549 regulations in the US and EU. Most EBSCO products are substantially conformant with WCAG 2.2 level AA." Source: https://connect.ebsco.com/s/article/EBSCO-VPATs?language=en_US. Last accessed April 22, 2025.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note	Description based on print version record and CIP data provided by publisher.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc	Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note	Introduction to managed entry agreements -- From coverage with evidence development to individual performance-based agreements in Italy -- Coverage with evidence development for multiple sclerosis drugs in the UK -- a "costly failure"? -- Novel funding models for expensive therapies -- Definition and classification of MEAs -- Country comparison of the implementation of managed entry agreements.
520 ## - SUMMARY, ETC.
Summary, etc.	"Managed Entry Agreements and Funding for Expensive Therapies examines the concept of MEA, detailing how depreciation of some specific therapies through intangible amortization is unavoidable"--
Assigning source	Provided by publisher.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element
General subdivision	Cost control.
9 (RLIN)	64241
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element
General subdivision	Testing.
9 (RLIN)	64242
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element
General subdivision	Prices.
9 (RLIN)	64243
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element
9 (RLIN)	64244
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term	Electronic books.
9 (RLIN)	58574
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name	Jaroslawski, Szymon,
Relator term	author.
9 (RLIN)	64245
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information	Print version:
Main entry heading	Toumi, Mondher.
Title	Managed entry agreements and funding for expensive therapies
Edition	First edition.
Place, publisher, and date of publication	Boca Raton : CRC Press, 2022
International Standard Book Number	9780367500269
Record control number	(DLC) 2021059395
856 40 - ELECTRONIC LOCATION AND ACCESS
Materials specified	EBSCOhost
Uniform Resource Identifier	<a href="https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3282745">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3282745</a>
938 ## -
--	YBP Library Services
--	YANK
--	302877341
938 ## -
--	EBSCOhost
--	EBSC
--	3282745
994 ## -
--	92
--	N$T

No items available.